Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment
    • Private equity firms...

    Private equity firms invest record 8.2 billion dollar in June quarter

    Written by Ruby Khatun Khatun Published On 2018-07-01T10:30:02+05:30  |  Updated On 1 July 2018 10:30 AM IST
    Private equity firms invest record 8.2 billion dollar in June quarter

    New Delhi: Private equity firms invested a record $8.2 billion across 158 deals during the quarter ended June, up 60 percent over the year-ago period, largely driven by big-ticket deals, says a report.


    According to the data from deal tracking firm Venture Intelligence, in the June quarter of 2017, there were $5.1 billion PE investments by way of 153 deals.


    "Not even five years ago, in 2013, $8 billion was the figure for PE capital that got invested during the entire year. Exceeding that in just one quarter, shows the extent of the confidence bounce back among investors for the Indian PE asset class, as well as in the macro environment," Venture Intelligence CEO Arun Natarajan said.


    Following the $8.2 billion PE investments announced in June quarter, the total investments in the first half of 2018 increased to $12.4 billion across 315 deals.


    PE deal activity this quarter was largely driven by big-ticket transactions as there were 24 PE investments worth $100 million or more (accounting for almost 83 percent of the total investment value during the period) compared to just 10 such transactions in the June quarter of last year.


    The biggest PE investments reported during the June quarter this year included the investment by Partners Group in GlobalLogic for about $960 million, followed by Temasek's contribution of about $760 million to the buyout of L&T Electrical & Automation Business by Schneider Electric.


    The IT & ITeS companies accounted for 31 percent of the PE investment, accounting for 83 deals worth $2.6 billion.


    Manufacturing companies, led by the L&T E&A Business, attracted 16 per cent of the investment ( $1.3 billion across seven deals), healthcare and life sciences companies (led by ChrysCapital's $350 million in Mankind Pharma) accounted for 12 per cent and Energy companies (led by the Greenko Group investment) for 10 per cent, the report said.


    These figures include venture capital investments, but exclude PE investments in real estate.

    Arun NatarajanChrysCapitalGlobalLogicJune quarterPE investmentsPrivate equityprivate equity firmsVenture Intelligence
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok